GoodRx (GDRX)
$4.84 0.4%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
7 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on GoodRx, AI stock picks, stock alerts and much more.
GDRX AI Stock Analysis
AI stock analysis for GDRX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like GoodRx (GDRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
GDRX Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of GoodRx (GDRX), currently trading at $4.84, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GDRX
-
GoodRx Holdings, Inc.
-
Symbol
GDRX
-
Market
NASDAQ
-
Industry
Medical - Healthcare Information Services
-
Market Cap
1.8B
Similar Stocks
 |
Cue Health HLTH |
$0.0434 29.8% |
2 |
 |
Sharecare SHCR |
$1.43 0.00% |
4 |
 |
GE HealthCare GEHC |
$83.22 0.3% |
5 |
 |
Schrodinger SDGR |
$22.57 2.5% |
9 |
 |
Spok SPOK |
$16.41 0.4% |
4 |
News
GDRX Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
Instagram Followers
Sign up to access
Youtube Subscribers
Sign up to access
App Downloads
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
GDRX Financials
GDRX Key Metrics
-
Total Revenue
$200.6M
-
Net Income
$6.7M
-
Earnings per Share
$0.0178
-
Free cash flow
-$7.5M
-
EBITDA
$37.6M
-
EBITDA Ratio
0.187344
-
Total Assets
$1.5B
GDRX 2-year Revenue & Income
GDRX 2-year Free Cash Flow
GDRX Technicals
GDRX SMA
GDRX RSI
FAQ
What's the current price of GoodRx (GDRX) Stock?
The price of an GoodRx (GDRX) share is $4.84.
What's the market cap of GoodRx?
The current market cap of GoodRx is 1.8B.
Should I buy or sell GDRX?
GoodRx shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, GoodRx is better viewed as a hold or accumulate position while waiting for further developments.
Is GoodRx a good investment?
The current analysis of GoodRx's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in GoodRx's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy GoodRx (GDRX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for GoodRx stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to GoodRx (GDRX) that investors often compare it to?
GoodRx (GDRX) is often compared to similar stocks such as Cue Health, Sharecare, GE HealthCare, Schrodinger and Spok.
What is the forecast for GoodRx's stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast GoodRx's stock price to be around $4.92 in 2025. Starting from the current price of $4.84, this represents a 1.6% change in price, indicating a neutral outlook for the stock.
How to buy GoodRx (GDRX) Stock?
GoodRx stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy GoodRx shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.